You just read:

LIGAND PHARMACEUTICALS INVESTOR ALERT: Hagens Berman is Investigating Ligand Pharmaceuticals' Accounting Restatements and Possible Securities Law Violations

News provided by

Hagens Berman Sobol Shapiro LLP

Nov 17, 2016, 09:30 ET